نتایج جستجو برای: adverse drug reactions adrs

تعداد نتایج: 850498  

2012
Arzu Didem Yalcin Atil Bisgin Reginald M. Gorczynski Ayse Akman Gülgün ErdoĐan Olcay Yegin

patients. Methods: A cross-sectional study with a questionnaire for adverse drug reactions based on European Network for Drug Allergy (ENDA) was performed. Hospitalized patients older than 12 years of age were included. Results: A total of 150 patients were studied, 84 being female. Their ages ranged from 14 to 94 years, with an average of 55 years. The average number of medications per patient...

2012
Michael Balduzzi Daanish Rashid Ahmed Butt Richard F. Lockey Dennis Ledford

patients. Methods: A cross-sectional study with a questionnaire for adverse drug reactions based on European Network for Drug Allergy (ENDA) was performed. Hospitalized patients older than 12 years of age were included. Results: A total of 150 patients were studied, 84 being female. Their ages ranged from 14 to 94 years, with an average of 55 years. The average number of medications per patient...

Journal: :Lijecnicki vjesnik 2010
Nikica Mirosević Skvrce Nada Bozina Viola Macolić Sarinić Sinisa Tomić

Hydroxymethylglutaryl-CoA reductase inhibitors (statins) are drugs used in the treatment of chronic diseases and frequently in concomitant therapy with many other drugs. Therefore, the risk of adverse drug reactions (ADRs), especially those caused by interactions is high. Aim of the study was to describe and analyze ADRs caused by statins reported to Croatian Agency from March 2005 to December ...

2012
P. P. Patel A. M. Gandhi C. K. Desai M. K. Desai R. K. Dikshit

Adverse drug reactions (ADRs) are one of the leading causes of death among hospitalized patients and occur in 0.3 to 7 per cent of all hospital admissions1. These may vary from mild rashes to severe reactions such as Stevens-Johnson syndrome (SJS). Five to eight per cent of hospitalized patient develop serious adverse drug reaction1. However, these may often go undetected and unreported. SJS is...

Journal: :Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 2009
Z Kourorian F Fattahi Z Pourpak M Rasoolinejad K Gholami

This study aimed to assess the frequency and severity of adverse drug reactions (ADRs) (WHO definition) in hospitalized adult patients in an infectious diseases referral ward in Tehran. Of 281 patients evaluated over 6 months, a total of 170 suspected ADRs were reported among 101 patients (35.9%). The most commonly affected organ system was gastrointestinal (47.5%), and the most common class of...

Journal: :Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique 2011
Colin J D Ross Henk Visscher S Rod Rassekh Lucila I Castro-Pastrana Evan Shereck Bruce Carleton Michael R Hayden

Adverse drug reactions (ADRs) rank as one of the top ten leading causes of death and illness in the developed world. In cancer therapy, more patients are surviving cancer than ever before, but 40% of cancer survivors suffer life-threatening or permanently disabling severe ADRs and are left with long-term sequelae. ADRs are often more frequent and more severe in children, and the consequences fo...

Journal: :Allergy 2009
P-J Bousquet P Demoly A Romano W Aberer A Bircher M Blanca K Brockow W Pichler M J Torres I Terreehorst B Arnoux M Atanaskovic-Markovic A Barbaud A Bijl P Bonadonna P G Burney S Caimmi G W Canonica J Cernadas B Dahlen J-P Daures J Fernandez E Gomes J-L Gueant M L Kowalski V Kvedariene P-M Mertes P Martins E Nizankowska-Mogilnicka N Papadopoulos C Ponvert M Pirmohamed J Ring M Salapatas M L Sanz A Szczeklik E Van Ganse A L De Weck T Zuberbier H F Merk B Sachs A Sidoroff

Nonallergic hypersensitivity and allergic reactions are part of the many different types of adverse drug reactions (ADRs). Databases exist for the collection of ADRs. Spontaneous reporting makes up the core data-generating system of pharmacovigilance, but there is a large under-estimation of allergy/hypersensitivity drug reactions. A specific database is therefore required for drug allergy and ...

Journal: :Pharmacogenomics 2011
William G Newman Katherine Payne Karen Tricker Stephen A Roberts Emily Fargher Sudeep Pushpakom Jane E Alder Gary P Sidgwick Debbie Payne Rachel A Elliott Marco Heise Robert Elles Simon C Ramsden Julie Andrews J Brian Houston Faeiza Qasim Jon Shaffer Christopher E M Griffiths David W Ray Ian Bruce William E R Ollier

AIM To conduct a pragmatic, randomized controlled trial to assess whether thiopurine methyltransferase (TPMT) genotyping prior to azathioprine reduces adverse drug reactions (ADRs). METHODS A total of 333 participants were randomized 1:1 to undergo TPMT genotyping prior to azathioprine or to commence treatment without genotyping. RESULTS There was no difference in the primary outcome of sto...

Journal: :International Journal of Applied Pharmaceutics 2021

The pandemic of Coronavirus Disease 2019 (COVID-19) has now affected the entire globe which was first surfaced in China December 2019. In absence effective therapy to manage COVID-19, repurposed therapies were being used condition. view an urgent need for definitive therapy, multiple drugs, and investigational drug candidates are tried clinical trials may lead emergence unknown short term long ...

2011
Daniel B Hawcutt Clare Pain Rachel Mulholland Lisa M Cann Gavin Cleary Michael W Beresford Eileen Baildam

Background & aims The Medicines and Healthcare Regulatory Authority (MHRA) in the UK runs a national spontaneous reporting system (Yellow Card Scheme) to collect ‘suspected’ Adverse Drug Reactions (ADRs) for all medicines. To increase the data for paediatric medicines, current MHRA advice is to report all suspected ADRs in paediatric patients. Yellow Cards submitted between 2000 and 2009 were a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید